Indication
Treatment of wild-type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM).
Medicine details
- Medicine name:
- vutrisiran (Amvuttra)
- SMC ID:
- SMC2900
- Pharmaceutical company
- Alnylam Pharmaceuticals
- BNF chapter
- Cardiovascular system
- Submission type
- Full
- Publication due date:
- TBC
- SMC meeting date:
- TBC
- Patient group submission deadline:
- TBC